I am excited to share my first author publication ✨🥳 I want to give a big thank you to the amazing collaborative effort done by @HarrisLabUTHSA@PapaStebLabs@BenDavidLab and @CancerInflam It was a pleasure working with you.
https://t.co/p2yo30cZl9
In our new paper just out in Science Advances we investigate mechanisms that may be limiting responses of KRAS mutant lung cancer to KRAS inhibitors and immunotherapy.
https://t.co/3ErFb9VBpm
How can we extend responses to KRASG12C drugs? Out now in @NatureComms, combining Revolution Medicines’ RAS(ON) G12C-selective inhibitor with a SHP2 inhibitor and immune checkpoint blockade to study their effects on KRAS-mutant lung tumours of varying immunogenicities.
Proud to share our groundbreaking findings on the variant-specific impacts of tumor suppressor genes in EML4-ALK lung cancer🫁 Proud to be first author with @EmilyShuldiner in this incredible collaboration‼️
@SotilloLab@LabWinslow Thread below ⬇️⬇️
How CDK phosphorylations are balanced during the cell cycle? We report in @CellReports how PP2A-B55 controls Ki67 function to maintain an organized mass of chromosomes during mitosis https://t.co/IArBbXQFqO
🎉Thank you to everyone who attended the 25th Beatson International Cancer Conference 2024 "Cancer Models: from Cages to Clinic" at the CRUK Scotland Institute this week!
We had a fantastic time and hope to see you all again soon🏴#BICC2024
Happy to share a new preprint from the CCCB lab: "Osmotic Stress Influences Microtubule Drug Response via WNK1 Kinase Signaling" This is part of the PhD thesis of the wonderful and talented @AnaMonfVen, a tour de force done fully from scratch and despite the COVID lockdown. 1/10
Join us for the 25th Anniversary Beatson International Cancer Conference 2024! #BICC2024
"Cancer Models: from Cages to Clinic"
📅8th - 11th July
📍@CRUK_SI, Glasgow, UK
🔗Register by 31st May: https://t.co/sQQQsomiXk
We are recruiting for 3 PhD student positions, investigating different aspects of the lung cancer tumour microenvironment, within the context of an exciting EU collaboration! Great facilities & great teams! 🔬
https://t.co/VGvZ7vQTcN
Apply before 6th July!
We are wrapping up our BC^3 series with a special keynote from Dr. Wolf Fridman on Wednesday, June 26th at 11 AM EST. Join us for this dynamic lecture! #TLS@hollern_daniel
Beyond excited to share our work on the reciprocal interaction between metastatic cancer cells and AT2 cells now published @Dev_Cell ! 🧵 [1/15]
https://t.co/7p6cnzvyl6
We are looking for a post-doc with a background in immunology to work on the impact of RAS oncogenic signaling on the interaction of lung cancers with the immune system. Fully funded four year position at Francis Crick Institute in London. #Crick https://t.co/RFbqyRoLft
Job offer: We are seeking candidates to join a large network of national and international collaborators on Cancer Genomics. Available positions: Research Manager, Data Steward, Posdoctoral, Technician in Genomics. More info: https://t.co/rqeOt43pR2 @VHIO https://t.co/rXNPJ6Xz1V